Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856056) titled 'Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH' on Sept. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Sultan Qaboos University

Condition: Migraine

Intervention: Drug: Nortriptyline

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: May 2027

Target Sample Size: 90

Countries of Recruitment: Oman

To know more, visit https://clinicaltrials.gov/study/NCT07856056

Disclaimer: Curated by HT Syndication....